fhB7H3.CAR-Ts Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: B7H3 targeting chimeric antigen receptor T cells

Pipeline

Phase 1/2: 2

Top Sponsors

The Affiliated Hospital of Xuzhou Medical University2

Indications

Cancer2
Liver Disease1
Ovarian Cancer1
Liver Cancer1
Hepatocellular Carcinoma1

Other2 trials

Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

Phase 1/2

Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.